Targeting dendritic cells in vivo for cancer therapy

Frontiers in Immunology

Volumn 3, Issue FEB, 2012, Pages

  Caminschi, Irina ^a,b   Maraskovsky, Eugene ^c   Heath, William Ross ^b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CSL LIMITED   (Australia)

Author keywords

Antigen delivery; Dendritic cell subsets; Dendritic cells; Targeting; Vaccine

Indexed keywords

EID: 84872005280     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00013     Document Type: Review

References (150)

1. Akiyama, K., Ebihara, S., Yada, A., Matsumura, K., Aiba, S., Nukiwa, T., and Takai, T. (2003). Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells. J. Immunol. 170, 1641-1648.
2. Albert, M., Jegathesan, M., and Darnell, R. (2001). Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat. Immunol. 2, 1010-1017.
3. Allan, R. S., Smith, C. M., Belz, G. T., van Lint, A. L., Wakim, L. M., Heath, W. R., and Carbone, F. R. (2003). Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science 301, 1925-1928.
4. Allan, R. S., Waithman, J., Bedoui, S., Jones, C. M., Villadangos, J. A., Zhan, Y., Lew, A. M., Shortman, K., Heath, W. R., and Carbone, F. R. (2006). Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25, 153-162.
5. Asano, K., Nabeyama, A., Miyake, Y., Qiu, C. H., Kurita, A., Tomura, M., Kanagawa, O., Fujii, S., and Tanaka, M. (2011). CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 34, 85-95.
6. Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I., Yessaad, N., Dezutter-Dambuyant, C., Vicari, A., O'Garra, A., Biron, C., Briere, F., and Trinchieri, G. (2001). Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2, 1144-1150.
7. Bachem, A., Guttler, S., Hartung, E., Ebstein, F., Schaefer, M., Tannert, A., Salama, A., Movassaghi, K., Opitz, C., Mages, H. W., Henn, V., Kloetzel, P. M., Gurka, S., and Kroczek, R. A. (2010). Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells. J. Exp. Med. 207, 1273-1281.
8. Backer, R., Schwandt, T., Greuter, M., Oosting, M., Jungerkes, F., Tuting, T., Boon, L., O'Toole, T., Kraal, G., Limmer, A., and den Haan, J. M. (2010). Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells. Proc. Natl. Acad. Sci. U.S.A. 107, 216-221.
9. Baker, K., Qiao, S. W., Kuo, T. T., Aveson, V. G., Platzer, B., Andersen, J. T., Sandlie, I., Chen, Z., de Haar, C., Lencer, W. I., Fiebiger, E., and Blumberg, R. S. (2011). Neonatal Fc recep- tor for IgG (FcRn) regulates cross- presentation of IgG immune com- plexes by CD8-CD11b+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 108, 9927-9932.
10. Bedoui, S., Whitney, P. G., Waithman, J., Eidsmo, L., Wakim, L., Caminschi, I., Allan, R. S., Wojtasiak, M., Shortman, K., Carbone, F. R., Brooks, A. G., and Heath, W. R. (2009). Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10, 488-495.
11. Belz, G. T., Behrens, G. M., Smith, C. M., Miller, J. F., Jones, C., Lejon, K., Fathman, C. G., Mueller, S. N., Shortman, K., Carbone, F. R., and Heath, W. R. (2002). The CD8alpha(+) den- dritic cell is responsible for inducing peripheral self-tolerance to tissue- associated antigens. J. Exp. Med. 196, 1099-1104.
12. Belz, G. T., Shortman, K., Bevan, M. J., and Heath, W. R. (2005). CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175, 196-200.
13. Belz, G. T., Smith, C. M., Eichner, D., Shortman, K., Karupiah, G., Carbone, F. R., and Heath, W. R. (2004a). Cutting edge: conventional CD8alpha(+) dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172, 1996-2000.
14. Belz, G. T., Smith, C. M., Kleinert, L., Reading, P., Brooks, A., Shortman, K., Carbone, F. R., and Heath, W. R. (2004b). Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. U.S.A. 101, 8670-8675.
15. Bennett, S. R., Carbone, F. R., Toy, T., Miller, J. F., and Heath, W. R. (1998). B cells directly tolerize CD8(+)T cells. J. Exp. Med. 188, 1977-1983.
16. Birkholz, K., Schwenkert, M., Kellner, C., Gross, S., Fey, G., Schuler-Thurner, B., Schuler, G., Schaft, N., and Dorrie, J. (2010). Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood 116, 2277-2285.
17. Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., and Steinman, R. M. (2002). Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627-1638.
18. Bonifaz, L.C., Bonnyay, D. P., Charalambous, A., Darguste, D. I., Fujii, S., Soares, H., Brimnes, M. K., Moltedo, B., Moran, T. M., and Steinman, R. M. (2004). In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815-824.
19. Boscardin, S. B., Hafalla, J. C., Masilamani, R. F., Kamphorst, A. O., Zebroski, H. A., Rai, U., Morrot, A., Zavala, F., Steinman, R. M., Nussenzweig, R. S., and Nussenzweig, M. C. (2006). Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203, 599-606.
20. Bozzacco, L., Trumpfheller, C., Siegal, F. P., Mehandru, S., Markowitz, M., Carrington, M., Nussenzweig, M. C., Piperno, A. G., and Steinman, R. M. (2007). DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc. Natl. Acad. Sci. U.S.A. 104, 1289-1294.
21. Bruder, D., Westendorf, A. M., Hansen, W., Prettin, S., Gruber, A. D., Qian, Y., von Boehmer, H., Mahnke, K., and Buer, J. (2005). On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54, 3395-3401.
22. Bursch, L. S., Wang, L., Igyarto, B., Kissenpfennig, A., Malissen, B., Kaplan, D. H., and Hogquist, K. A. (2007). Identification of a novel population of Langerin+ dendritic cells. J. Exp. Med. 204, 3147-3156.
23. Caminschi, I., Lahoud, M. H., and Shortman, K. (2009). Enhancing immune responses by targeting antigentoDC. Eur. J. Immunol. 39, 931-938.
24. Caminschi, I., Proietto, A. I., Ahmet, F., Kitsoulis, S., Shin Teh, J., Lo, J. C., Rizzitelli, A., Wu, L., Vremec, D., van Dommelen, S. L., Campbell, I. K., Maraskovsky, E., Braley, H., Davey, G. M., Mottram, P., van de Velde, N., Jensen, K., Lew, A. M., Wright, M. D., Heath, W. R., Shortman, K., and Lahoud, M. H. (2008). The dendritic cell subtype- restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112, 3264-3273.
25. Caminschi, I., Vremec, D., Ahmet, F., Lahoud, M. H., Villadangos, J. A., Murphy, K. M., Heath, W. R., and Shortman, K. (2011). Antibody responses initiated by Clec9A- bearing dendritic cells in normal and Batf3(-/-) mice. Mol. Immunol. doi: org/10.1016/j.molimm.2011.11.008. [Epub ahead of print].
26. Carter, R. W., Thompson, C., Reid, D. M., Wong, S. Y., and Tough, D. F. (2006). Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendriticcell-associatedC-typelectin-1. J. Immunol. 177, 2276-2284.
27. Castro, F. V., Tutt, A. L., White, A. L., Teeling, J. L., James, S., French, R. R., and Glennie, M. J. (2008). CD11c provides an effective immunotar- get for the generation of both CD4 and CD8 T cell responses. Eur. J. Immunol. 38, 2263-2273.
28. Charalambous, A., Oks, M., Nchinda, G., Yamazaki, S., and Steinman, R. M. (2006). Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin. J. Immunol. 177, 8410-8421.
29. Crozat, K., Guiton, R., Contreras, V., Feuillet, V., Dutertre, C. A., Ventre, E., Vu Manh, T. P., Baranek, T., Storset, A. K., Marvel, J., Boudinot, P., Hosmalin, A., Schwartz-Cornil, I., and Dalod, M. (2010). The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J. Exp. Med. 207, 1283-1292.
30. + type. J. Immunol. 187, 4411-4415.
31. Cruz, L. J., Tacken, P. J., Bonetto, F., Buschow, S. I., Croes, H. J., Wijers, M., de Vries, I. J., and Figdor, C. G. (2011a). Multimodal imaging of nanovaccine carriers targeted to human dendritic cells. Mol. Pharm. 8, 520-531.
32. Cruz, L. J., Tacken, P. J., Fokkink, R., and Figdor, C. G. (2011b). The influence of PEG chain length and targeting moiety onantibody-mediated delivery of nanoparticle vaccines to human dendritic cells. Biomaterials 32, 6791-6803.
33. Cruz, L. J., Tacken, P. J., Fokkink, R., Joosten, B., Stuart, M. C., Albericio, F., Torensma, R., and Figdor, C. G. (2010). Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic Caminschi et al. Targeting dendritic cells for immunotherapy cells via DC-SIGN in vitro. J. Control Release 144, 118-126.
34. DeVries, I. J., Krooshoop, D. J., Scharenborg, N. M., Lesterhuis, W. J., Diepstra, J. H., Van Muijen, G. N., Strijk, S. P., Ruers, T. J., Boerman, O. C., Oyen, W. J., Adema, G. J., Punt, C. J., and Figdor, C. G. (2003). Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res. 63, 12-17.
35. del Rio, M. L., Rodriguez-Barbosa, J. I., Kremmer, E., and Forster, R. (2007). CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178, 6861-6866.
36. Delneste, Y., Magistrelli, G., Gauchat, J., Haeuw, J., Aubry, J., Nakamura, K., Kawakami-Honda, N., Goetsch, L., Sawamura, T., Bonnefoy, J., and Jeannin, P. (2002). Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17, 353-362.
37. den Haan, J. M., and Bevan, M. J. (2002). Constitutive versus activation- dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J. Exp. Med. 196, 817-827.
38. den Haan, J. M., Lehar, S. M., and Bevan, M. J. (2000). CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685-1696.
39. Desch, A. N., Randolph, G. J., Murphy, K., Gautier, E. L., Kedl, R. M., Lahoud, M. H., Caminschi, I., Shortman, K., Henson, P. M., and Jakubzick, C. V. (2011). CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cellassociated antigen. J. Exp. Med. 208, 1789-1797.
40. Dickgreber, N., Stoitzner, P., Bai, Y., Price, K. M., Farrand, K. J., Manning, K., Angel, C. E., Dunbar, P. R., Ronchese, F., Fraser, J. D., Bäckström, B. T., and Hermans, I. F. (2009). Targeting antigen to MHC class II molecules promotes efficient cross-presentation and enhances immunotherapy. J. Immunol. 182, 1260-1269.
41. Do, Y., Park, C. G., Kang, Y. S., Park, S. H., Lynch, R. M., Lee, H., Powell, B. S., and Steinman, R. M. (2008). Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205- positive mouse dendritic cells. Eur. J. Immunol. 38, 20-29.
42. Dominguez, A. L., and Lustgarten, J. (2010). Targeting the tumor microenvironment with antineu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses. Vaccine 28, 1383-1390.
43. Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H. W., Park, C. G., Steinman, R. M., and Nussenzweig, M. C. (2007). Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107-111.
44. Durantez, M., Fayolle, C., Casares, N., Belsue, V., Riezu-Boj, J. I., Sarobe, P., Prieto, J., Borras-Cuesta, F., Leclerc, C., and Lasarte, J. J. (2010). Tumor therapy in mice by using a tumor antigen linked to modulin peptides from Staphylococcus epidermidis. Vaccine 28, 7146-7154.
45. Edelson, B. T., Kc, W., Juang, R., Kohyama, M., Benoit, L. A., Klekotka, P. A., Moon, C., Albring, J. C., Ise, W., Michael, D. G., Bhattacharya, D., Stappenbeck, T. S., Holtzman, M. J., Sung, S. S., Murphy, T. L., Hildner, K., and Murphy, K. M. (2010). Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 207, 823-836.
46. Eubel, J., and Enk, A. H. (2009). Dendritic cell vaccination as a treatment modality for melanoma. Expert Rev. Anticancer Ther. 9, 1631-1642.
47. Farrand, K. J., Dickgreber, N., Stoitzner, P., Ronchese, F., Petersen, T. R., and Hermans, I. F. (2009). Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens. J. Immunol. 183, 7732-7742.
48. Fayolle, C., Ladant, D., Karimova, G., Ullmann, A., and Leclerc, C. (1999). Therapy of murine tumors with recombinant Bordetella pertussis adenylate cyclase carrying a cytotoxic T cell epitope. J. Immunol. 162, 4157-4162.
49. Flacher, V., Tripp, C. H., Stoitzner, P., Haid, B., Ebner, S., Del Frari, B., Koch, F., Park, C. G., Steinman, R. M., Idoyaga, J., and Romani, N. (2010). Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis. J. Invest. Dermatol. 130, 755-762.
50. Flores-Langarica, A., Meza-Perez, S., Calderon-Amador, J., Estrada-Garcia, T., Macpherson, G., Lebecque, S., Saeland, S., Steinman, R. M., and Flores-Romo, L. (2005). Network of dendritic cells within the muscular layer of the mouse intestine. Proc. Natl. Acad. Sci. U.S.A. 102, 19039-19044.
51. Flynn, B. J., Kastenmuller, K., Wille-Reece, U., Tomaras, G. D., Alam, M., Lindsay, R. W., Salazar, A. M., Perdiguero, B., Gomez, C. E., Wagner, R., Esteban, M., Park, C. G., Trumpfheller, C., Keler, T., Pantaleo, G., Steinman, R. M., and Seder, R. (2011). Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates. Proc. Natl. Acad. Sci. U.S.A. 108, 7131-7136.
52. GeurtsvanKessel, C. H., Willart, M. A., van Rijt, L. S., Muskens, F., Kool, M., Baas, C., Thielemans, K., Bennett, C., Clausen, B. E., Hoogsteden, H. C., Osterhaus, A. D., Rimmelzwaan, G. F., and Lambrecht, B. N. (2008). Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasma-cytoid dendritic cells. J. Exp. Med. 205, 1621-1634.
53. Ginhoux, F., Liu, K., Helft, J., Bogunovic, M., Greter, M., Hashimoto, D., Price, J., Yin, N., Bromberg, J., Lira, S. A., Stanley, E. R., Nussenzweig, M., and Merad, M. (2009). The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115-3130.
54. Giodini, A., Rahner, C., and Cresswell, P. (2009). Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells. Proc. Natl. Acad. Sci. U.S.A. 106, 3324-3329.
55. Guermonprez, P., Fayolle, C., Rojas, M. J., Rescigno, M., Ladant, D., and Leclerc, C. (2002). In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c+CD8 alpha -CD11bhigh dendritic cells. Eur. J. Immunol. 32, 3071-3081.
56. Gurer, C., Strowig, T., Brilot, F., Pack, M., Trumpfheller, C., Arrey, F., Park, C. G., Steinman, R. M., and Munz, C. (2008). Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood 112, 1231-1239.
57. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., and Nussenzweig, M. C. (2001). Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779.
58. He, L. Z., Crocker, A., Lee, J., Mendoza-Ramirez, J., Wang, X. T., Vitale, L. A., O'Neill, T., Petromilli, C., Zhang, H. F., Lopez, J., Rohrer, D., Keler, T., and Clynes, R. (2007). Antigenic targeting of the human mannose receptor induces tumor immunity. J. Immunol. 178, 6259-6267.
59. He, L. Z., Ramakrishna, V., Connolly, J. E., Wang, X. T., Smith, P. A., Jones, C. L., Valkova-Valchanova, M., Arunakumari, A., Treml, J. F., Goldstein, J., Wallace, P. K., Keler, T., and Endres, M. J. (2004). A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropin beta. Clin. Cancer Res. 10, 1920-1927.
60. Heath, W. R., and Carbone, F. R. (2009). Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10, 1237-1244.
61. Henri, S., Poulin, L. F., Tamoutounour, S., Ardouin, L., Guilliams, M., de Bovis, B., Devilard, E., Viret, C., Azukizawa, H., Kissenpfennig, A., and Malissen, B. (2010). CD207+ CD103+ dermal dendritic cells cross-present keratinocyte-derived antigens irrespective of the presence of Langerhans cells. J. Exp. Med. 207, 189-206.
62. Henri, S., Vremec, D., Kamath, A., Waithman, J., Williams, S., Benoist, C., Burnham, K., Saeland, S., Handman, E., and Shortman, K. (2001). The dendritic cell populations of mouse lymph nodes. J. Immunol. 167, 741-748.
63. Higano, C.S., Schellhammer, P.F., Small, E. J., Burch, P. A., Nemunaitis, J., Yuh, L., Provost, N., and Frohlich, M. W. (2009). Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer. Cancer 115, 3670-3679.
64. Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., Schreiber, R. D., Murphy, T. L., and Murphy, K. M. (2008). Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100.
65. Hochrein, H., Shortman, K., Vremec, D., Scott, B., Hertzog, P., and O'Keeffe, M. (2001). Differential production of IL-12, IFN-alpha, and IFN- gamma by mouse dendritic cell subsets. J. Immunol. 166, 5448-5455.
66. Huleatt, J. W., and Lefrancois, L. (1995). Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J. Immunol. 154, 5684-5693.
67. Huysamen, C., Willment, J.A., Dennehy, K. M., and Brown, G. D. (2008). CLEC9A is a novel activation C- type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J. Biol. Chem. 283, 16693-16701.
68. Idoyaga, J., Lubkin, A., Fiorese, C., Lahoud, M. H., Caminschi, I., Huang, Y., Rodriguez, A., Clausen, B. E., Park, C. G., Trumpfheller, C., and Steinman, R. M. (2011). Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. U.S.A. 108, 2384-2389.
69. Igyarto, B. Z., Haley, K., Ortner, D., Bobr, A., Gerami-Nejad, M., Edelson, B. T., Zurawski, S. M., Malissen, B., Zurawski, G., Berman, J., and Kaplan, D. H. (2011). Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity 35, 260-272.
70. Inaba, K., Swiggard, W. J., Inaba, M., Meltzer, J., Mirza, A., Sasagawa, T., Nussenzweig, M. C., and Steinman, R. M. (1995). Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC- 145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163, 148-156.
71. Iwasaki, A., and Kelsall, B. L. (2001). Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J. Immunol. 166, 4884-4890.
72. Iyoda, T., Shimoyama, S., Liu, K., Omatsu, Y., Akiyama, Y., Maeda, Y., Takahara, K., Steinman, R. M., and Inaba, K. (2002). The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195, 1289-1302.
73. Joffre, O. P., Sancho, D., Zelenay, S., Keller, A. M., and Reis, E. S. C. (2010). Efficient and versatile manipulation of the peripheral CD4(+) T-cell compartment by antigen targeting to DNGR- 1/CLEC9A. Eur. J. Immunol. 40, 1255-1265.
74. Johnson, T. S., Mahnke, K., Storn, V., Schonfeld, K., Ring, S., Nettelbeck, D. M., Haisma, H. J., Le Gall, F., Kontermann, R. E., and Enk, A. H. (2008). Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC205 single-chain fragment variable molecule. Clin. Cancer Res. 14, 8169-8177.
75. Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C. J., Dunbar, P. R., Wadley, R. B., Jeet, V., Vulink, A. J., Hart, D. N., and Radford, K. J. (2010). Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207, 1247-1260.
76. Joshi, M. D., Unger, W. W., van Beelen, A. J., Bruijns, S. C., Litjens, M., van Bloois, L., Kalay, H., van Kooyk, Y., and Storm, G. (2011). DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations. Int. J. Pharm. 416, 426-432.
77. Kamath, A. T., Henri, S., Battye, F., Tough, D. F., and Shortman, K. (2002). Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100, 1734-1741.
78. Kamath, A. T., Pooley, J., O'Keeffe, M. A., Vremec, D., Zhan, Y., Lew, A. M., D'Amico, A., Wu, L., Tough, D. F., and Shortman, K. (2000). The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165, 6762-6770.
79. Kamphorst, A. O., Guermonprez, P., Dudziak, D., and Nussenzweig, M. C. (2010). Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes. J. Immunol. 185, 3426-3435.
80. Keler, T., He, L., Ramakrishna, V., and Champion, B. (2007). Antibodytargeted vaccines. Oncogene 26, 3758-3767.
81. Kim, T. S., and Braciale, T. J. (2009). Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE 4, e4204. doi:10.1371/journal.pone.0004204.
82. Klechevsky, E., Flamar, A. L., Cao, Y., Blanck, J. P., Liu, M., O'Bar, A., Agouna-Deciat, O., Klucar, P., Thompson-Snipes, L., Zurawski, S., Reiter, Y., Palucka, A. K., Zurawski, G., and Banchereau, J. (2010). Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 116, 1685-1697.
83. Kratzer, R., Mauvais, F. X., Burgevin, A., Barilleau, E., and van Endert, P. (2010). Fusion proteins for versatile antigen targeting to cell surface receptors reveal differential capacity to prime immune responses. J. Immunol. 184, 6855-6864.
84. Kretschmer, K., Apostolou, I., Hawiger, D., Khazaie, K., Nussenzweig, M. C., and von Boehmer, H. (2005). Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6, 1219-1227.
85. Kretz-Rommel, A., Qin, F., Dakappagari, N., Torensma, R., Faas, S., Wu, D., and Bowdish, K. S. (2007). In vivo targeting of antigens to human dendritic cells through DC-SIGN elicits stimulatory immune responses and inhibits tumor growth in grafted mouse models. J. Immunother. 30, 715-726.
86. Kwon, Y. J., James, E., Shastri, N., and Frechet, J. M. (2005). In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc. Natl. Acad. Sci. U.S.A. 102, 18264-18268.
87. Lahoud, M. H., Ahmet, F., Kitsoulis, S., Wan, S. S., Vremec, D., Lee, C. N., Phipson, B., Shi, W., Smyth, G. K., Lew, A. M., Kato, Y., Mueller, S. N., Davey, G. M., Heath, W. R., Shortman, K., and Caminschi, I. (2011). Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J. Immunol. 187, 842-850.
88. Lahoud, M. H., Proietto, A. I., Ahmet, F., Kitsoulis, S., Eidsmo, L., Wu, L., Sathe, P., Pietersz, S., Chang, H. W., Walker, I. D., Maraskovsky, E., Braley, H., Lew, A. M., Wright, M. D., Heath, W. R., Shortman, K., and Caminschi, I. (2009). The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses. J. Immunol. 182, 7587-7594.
89. Laouar, Y., Sutterwala, F. S., Gorelik, L., and Flavell, R. A. (2005). Transforming growth factor-beta controls Thelper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 6, 600-607.
90. Lesterhuis, W. J., Aarntzen, E. H., De Vries, I. J., Schuurhuis, D. H., Figdor, C. G., Adema, G. J., and Punt, C. J. (2008). Dendritic cell vaccines in melanoma: from promise to proof? Crit. Rev. Oncol. Hematol. 66, 118-134.
91. Lin, M. L., Zhan, Y., Proietto, A. I., Prato, S., Wu, L., Heath, W. R., Villadangos, J. A., and Lew, A. M. (2008). Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc. Natl. Acad. Sci. U.S.A. 105, 3029-3034.
92. Liu, K., Victora, G. D., Schwickert, T. A., Guermonprez, P., Meredith, M. M., Yao, K., Chu, F. F., Randolph, G. J., Rudensky, A. Y., and Nussenzweig, M. (2009). In vivo analysis of dendritic cell development and homeostasis. Science 324, 392-397.
93. Liu, K., Waskow, C., Liu, X., Yao, K., Hoh, J., and Nussenzweig, M. (2007). Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8, 578-583.
94. Liu, Y. J. (2005). IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306.
95. Longhi, M. P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A. M., Colonna, M., and Steinman, R. M. (2009). Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206, 1589-1602.
96. Loschko, J., Schlitzer, A., Dudziak, D., Drexler, I., Sandholzer, N., Bourquin, C., Reindl, W., and Krug, A. B. (2011). Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cellmediated immunity. J. Immunol. 186, 6718-6725.
97. Lukens, M. V., Kruijsen, D., Coenjaerts, F. E., Kimpen, J. L., and van Bleek, G. M. (2009). Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node. J. Virol. 83, 7235-7243.
98. Mahnke, K., Guo, M., Lee, S., Sepulveda, H., Swain, S. L., Nussenzweig, M., and Steinman, R. M. (2000). The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151, 673-684.
99. Mahnke, K., Qian, Y., Fondel, S., Brueck, J., Becker, C., and Enk, A. H. (2005). Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res. 65, 7007-7012.
100. Mahnke, K., Qian, Y., Knop, J., and Enk, A. H. (2003). Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101, 4862-4869.
101. Maldonado-Lopez, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B Heirman, C., Thielemans, K., Leo, O., Urbain, J., and Moser, M. (1999). CD8alpha+ and CD8alpha- sub-classes of dendritic cells direct the development of distinct T helper cellsinvivo.J. Exp. Med. 189, 587-592.
102. Meyer-Wentrup, F., Benitez-Ribas, D., Tacken, P. J., Punt, C. J., Figdor, C. G., de Vries, I. J., and Adema, G. J. (2008). Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111, 4245-4253.
103. Morse, M. A., Coleman, R. E., Akabani, G., Niehaus, N., Coleman, D., and Lyerly, H. K. (1999). Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59, 56-58.
104. Mukhopadhaya, A., Hanafusa, T., Jarchum, I., Chen, Y. G., Iwai, Y., Serreze, D. V., Steinman, R. M., Tarbell, K. V., and DiLorenzo, T. P. (2008). Selective delivery of {beta} cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Proc. Natl. Acad. Sci. U.S.A. 105, 6374-6379.
105. Naik, S., Vremec, D., Wu, L., O'Keeffe, M., and Shortman, K. (2003). CD8alpha+ mouse spleen dendritic cells do not originate from the CD8alpha- dendritic cell subset. Blood 102, 601-604.
106. Naik, S. H., Metcalf, D., van Nieuwenhuijze, A., Wicks, I., Wu, L., O'Keeffe, M., and Shortman, K. (2006). Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7, 663-671.
107. Nchinda, G., Kuroiwa, J., Oks, M., Trumpfheller, C., Park, C. G., Huang, Y., Hannaman, D., Schlesinger, S. J., Mizenina, O., Nussenzweig, M. C., Uberla, K., and Steinman, R. M. (2008). The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells. J. Clin. Invest. 118, 1427-1436.
108. Palucka, A. K., Ueno, H., Fay, J., and Banchereau, J. (2008). Dendritic cells: a critical player in cancer therapy? J. Immunother. 31, 793-805.
109. Park, J. M., Terabe, M., Sakai, Y., Munasinghe, J., Forni, G., Morris, J. C., and Berzofsky, J. A. (2005). Early role of CD4+ Th1 cells and antibodies in HER-2 adenovirus vaccine protection against autochthonous mammary carcinomas. J. Immunol. 174, 4228-4236.
110. Pereira, C. F., Torensma, R., Hebeda, K., Kretz-Rommel, A., Faas, S. J., Figdor, C. G., and Adema, G. J. (2007). In vivo targeting of DC-SIGNpositive antigen-presenting cells in a nonhuman primate model. J. Immunother. 30, 705-714.
111. Platt, C. D., Ma, J. K., Chalouni, C., Ebersold, M., Bou-Reslan, H., Carano, R. A., Mellman, I., and Delamarre, L. (2010). Mature dendritic cells use endocytic receptors to capture and present antigens. Proc. Natl. Acad. Sci. U.S.A. 107, 4287-4292.
112. Pooley, J., Heath, W. R., and Shortman, K. (2001). Intravenous soluble antigen is presented to CD4 T cells by CD8dendritic cells but cross-presented to CD8+ Tcellsby CD8+ dendritic cells. J. Immunol. 166, 5327-5330.
113. Pulendran, B., Smith, J. L., Caspary, G., Brasel, K., Pettit, D., Maraskovsky, E., and Maliszewski, C. R. (1999). Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. U.S.A. 96, 1036-1041.
114. Ramakrishna, V., Treml, J. F., Vitale, L., Connolly, J. E., O'Neill, T., Smith, P. A., Jones, C. L., He, L. Z., Goldstein, J., Wallace, P. K., Keler, T., and Endres, M. J. (2004). Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J. Immunol. 172, 2845-2852.
115. Ramakrishna, V., Vasilakos, J. P., Tario, J. D. Jr., Berger, M. A., Wallace, P. K., and Keler, T. (2007). Toll-like receptor activation enhances cellmediated immunity induced by an antibody vaccine targeting human dendritic cells. J. Transl. Med. 5, 5.
116. Reddy, S. T., Swartz, M. A., and Hubbell, J. A. (2006). Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27, 573-579.
117. Robson, N. C., Hoves, S., Maraskovsky, E., and Schnurr, M. (2010). Presentation of tumour antigens by dendritic cells and challenges faced. Curr. Opin. Immunol. 22, 137-144.
118. Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martinez, D., Hernanz-Falcon, P., Rosewell, I., and Reis e Sousa, C. (2009). Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899-903.
119. Sancho, D., Mourao-Sa, D., Joffre, O. P., Schulz, O., Rogers, N. C., Pennington, D. J., Carlyle, J. R., and Reis e Sousa, C. (2008). Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 118, 2098-2110.
120. Schnorrer, P., Behrens, G. M., Wilson, N. S., Pooley, J. L., Smith, C. M., El-Sukkari, D., Davey, G., Kupresanin, F., Li, M., Maraskovsky, E., Belz, G. T., Carbone, F. R., Shortman, K., Heath, W. R., and Villadangos, J. A. (2006). The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. U.S.A. 103, 10729-10734.
121. Schulz, O., and Reis e Sousa, C. (2002). Cross-presentation of cell- associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107, 183-189.
122. Segura, E., Albiston, A. L., Wicks, I. P., Chai, S. Y., and Villadangos, J. A. (2009). Different cross- presentation pathways in steady- state and inflammatory dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 106, 20377-20381.
123. Shortman, K., and Heath, W. R. (2010). The CD8+ dendritic cell subset. Immunol. Rev. 234, 18-31.
124. Shortman, K., Lahoud, M. H., and Caminschi, I. (2009). Improving vaccines by targeting antigens to dendritic cells. Exp. Mol. Med. 41, 61-66.
125. Shortman, K., and Liu, Y. (2002). Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2, 151-161.
126. Shrimpton, R. E., Butler, M., Morel, A. S., Eren, E., Hue, S. S., and Ritter, M. A. (2009). CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self. Mol. Immunol. 46, 1229-1239.
127. Smith, C. M., Belz, G. T., Wilson, N. S., Villadangos, J. A., Shortman, K., Carbone, F. R., and Heath, W. R. (2003). Cutting edge: conventional CD8alpha(+) dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170, 4437-4440.
128. Soares, H., Waechter, H., Glaichenhaus, N., Mougneau, E., Yagita, H., Mizenina, O., Dudziak, D., Nussenzweig, M. C., and Steinman, R. M. (2007). A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12- independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204, 1095-1106.
129. Sung, S. S., Fu, S. M., Rose, C. E. Jr., Gaskin, F., Ju, S. T., and Beaty, S. R. (2006). A major lung CD103 (alphaE)-beta7 integrin- positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176, 2161-2172.
130. Tacken, P. J., de Vries, I. J., Gijzen, K., Joosten, B., Wu, D., Rother, R. P., Faas, S. J., Punt, C. J., Torensma, R., Adema, G. J., and Figdor, C. G. (2005). Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 106, 1278-1285.
131. Tacken, P. J., de Vries, I. J., Torensma, R., and Figdor, C. G. (2007). Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790-802.
132. Tagliani, E., Guermonprez, P., Sepulveda, J., Lopez-Bravo, M., Ardavin, C., Amigorena, S., Benvenuti, F., and Burrone, O. R. (2008). Selection of an antibody library identifies a pathway to induce immunity by targeting CD36 on steady-state CD8alpha+ dendritic cells. J. Immunol. 180, 3201-3209.
133. Tel, J., Benitez-Ribas, D., Hoosemans, S., Cambi, A., Adema, G. J., Figdor, C. G., Tacken, P. J., and de Vries, I. J. (2011). DEC-205 mediates antigen uptake and presentation by both resting and activated human plasmacytoid dendritic cells. Eur. J. Immunol. 41, 1014-1023.
134. Trumpfheller, C., Caskey, M., Nchinda, G., Longhi, M. P., Mizenina, O., Huang, Y., Schlesinger, S. J., Colonna, M., and Steinman, R. M. (2008). The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine. Proc. Natl. Acad. Sci. U.S.A. 105, 2574-2579.
135. Trumpfheller, C., Finke, J. S., Lopez, C. B., Moran, T. M., Moltedo, B., Soares, H., Huang, Y., Schlesinger, S. J., Park, C. G., Nussenzweig, M. C., Granelli-Piperno, A., and Steinman, R. M. (2006). Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203, 607-617.
136. Turnbull, E., and MacPherson, G. (2001). Immunobiology of dendritic cells in the rat. Immunol. Rev. 184, 58-68.
137. Vallon-Eberhard, A., Landsman, L., Yogev, N., Verrier, B., and Jung, S. (2006). Transepithelial pathogen uptake into the small intestinal lamina propria. J. Immunol. 176, 2465-2469.
138. van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., and Altin, J. G. (2004). Targeting dendritic cells with antigencontaining liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res. 64, 4357-4365.
139. Villadangos, J. A., and Schnorrer, P. (2007). Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7, 543-555.
140. Vingert, B., Adotevi, O., Patin, D., Jung, S., Shrikant, P., Freyburger, L., Eppolito, C., Sapoznikov, A., Amessou, M., Quintin-Colonna, F., Fridman, W. H., Johannes, L., and Tartour, E. (2006). The Shiga toxin B-subunit targets antigen in vivo to dendritic cells and elicits antitumor immunity. Eur. J. Immunol. 36, 1124-1135.
141. Vremec, D., Pooley, J., Hochrein, H., Wu, L., and Shortman, K. (2000). CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164, 2978-2986.
142. Wang, H., Griffiths, M. N., Burton, D. R., and Ghazal, P. (2000). Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization. Proc. Natl. Acad. Sci. U.S.A. 97, 847-852.
143. Wang, W. W., Das, D., and Suresh, M. R. (2009). A versatile bifunctional dendritic cell targeting vaccine vector. Mol. Pharm. 6, 158-172.
144. Wei, H., Wang, S., Zhang, D., Hou, S., Qian, W., Li, B., Guo, H., Kou, G., He, J., Wang, H., and Guo, Y. (2009). Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Clin. Cancer Res. 15, 4612-4621.
145. Wilson, N. S., El-Sukkari, D., Belz, G. T., Smith, C. M., Steptoe, R. J., Heath, W. R., Shortman, K., and Villadangos, J. A. (2003). Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102, 2187-2194.
146. Wilson, N. S., Young, L. J., Kupresanin, F., Naik, S. H., Vremec, D., Heath, W. R., Akira, S., Shortman, K., Boyle, J., Maraskovsky, E., Belz, G. T., and Villadangos, J. A. (2008). Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol. Cell Biol. 86, 200-205.
147. Witmer-Pack, M. D., Crowley, M. T., Inaba, K., and Steinman, R. M. (1993). Macrophages, but not dendritic cells, accumulate colloidal carbon following administration in situ. J. Cell. Sci. 105, 965-973.
148. Yamazaki, S., Dudziak, D., Heidkamp, G. F., Fiorese, C., Bonito, A. J., Inaba, K., Nussenzweig, M. C., and Steinman, R. M. (2008). CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J. Immunol. 181, 6923-6933.
149. Zhang, S. S., Park, C. G., Zhang, P., Bartra, S. S., Plano, G. V., Klena, J. D., Skurnik, M., Hinnebusch, B. J., and Chen, T. (2008). Plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. J. Biol. Chem. 283, 31511-31521.
150. Zhao, X., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M., and Iwasaki, A. (2003). Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197, 153-162.